Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development - Institut Pasteur Access content directly
Journal Articles Vaccine Year : 2019

Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development

Abstract

The generation of robust systemic and mucosal antibody and cell-mediated immune (CMI) responses that are protective, long-lasting, and can quickly be recalled upon subsequent re-exposure to the cognate antigen is the key to the development of effective vaccine candidates. These responses, whether they represent mechanistic or non-mechanistic immunological correlates of protection, usually entail the activation of T cell memory and effector subsets (T-CMI) and induction of long-lasting memory B cells. However, for ETEC and Shigella, the precise role of these key immune cells in primary and secondary (anamnestic) immune responses remains ill-defined. A workshop to address immune correlates for ETEC and Shigella, in general, and to elucidate the mechanistic role of T-cell subsets and B-cells, both systemically and in the mucosal microenvironment, in the development of durable protective immunity against ETEC and Shigella was held at the recent 2nd Vaccines against Shigella and ETEC (VASE) conference in June 2018. This report is a summary of the presentations and the discussion that ensued at the workshop.
Fichier principal
Vignette du fichier
1-s2.0-S0264410X1930372X-main.pdf (339.16 Ko) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

pasteur-02874931 , version 1 (23-06-2020)

Identifiers

Cite

Sachin Mani, Franklin Toapanta, Monica Mcarthur, Firdausi Qadri, Ann-Mari Svennerholm, et al.. Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development. Vaccine, 2019, 37 (34), pp.4787-4793. ⟨10.1016/j.vaccine.2019.03.040⟩. ⟨pasteur-02874931⟩

Collections

INSERM PASTEUR
82 View
121 Download

Altmetric

Share

Gmail Facebook X LinkedIn More